Rare diseases
Investigational molecules
Locations
Back to France1 745 clinical trials in Roubaix, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Atezolizumab for Patients with High-Risk Diffuse Large B-Cell Lymphoma
FranceStudy of BGB-11417 for Patients with Relapsed or Refractory Mantle Cell Lymphoma
FranceStudy of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation
FranceStudy on Bulevirtide Treatment for Patients with Chronic Hepatitis D
FranceStudy of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
FranceStudy Comparing Tirzepatide and Semaglutide for Weight Loss in Adults with Obesity or Overweight and Related Health Issues
BelgiumStudy on the Safety and Effectiveness of BCMACP03 for Patients with Relapsed or Refractory Multiple Myeloma
BelgiumStudy of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy
FranceStudy of Telisotuzumab Vedotin for Adults with Advanced Non-Squamous Non-Small Cell Lung Cancer
FranceLong-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases
FranceStudy on the Safety and Effects of Ixodes ricinus Contact Phase Inhibitor in Adults with Spontaneous Brain Bleeding
FranceStudy on Dupilumab Step-Down Strategy for Maintaining Remission in Adults and Adolescents with Atopic Dermatitis
FranceThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for Multiple Myeloma and various forms of leukemia, including comparative studies of novel therapeutic combinations and traditional approaches.
Studies evaluating treatment effectiveness in newly diagnosed patients and those with advanced disease stages.
Innovative research exploring potential treatments for Alzheimer's disease, including studies on caffeine's effects on cognitive function in early-to-moderate stage patients.
Focus on non-pharmacological interventions and their impact on disease progression.
Clinical investigations into severe asthma management and pulmonary infections, including studies on treatment optimization and novel therapeutic approaches.
Evaluation of long-term treatment strategies and comparative medication studies.
Research examining hypertension management in patients with chronic kidney disease, along with studies on thrombo-embolic complications prevention.
Focus on optimizing treatment strategies for complex cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
